Sivik Global Healthcare LLC Has $2.11 Million Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Sivik Global Healthcare LLC trimmed its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 50.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,000 shares of the medical equipment provider’s stock after selling 20,000 shares during the quarter. Sivik Global Healthcare LLC’s holdings in Zimmer Biomet were worth $2,113,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Gries Financial LLC bought a new stake in shares of Zimmer Biomet during the fourth quarter worth approximately $866,000. R Squared Ltd bought a new position in shares of Zimmer Biomet during the fourth quarter worth approximately $63,000. CKW Financial Group raised its position in shares of Zimmer Biomet by 11.7% in the fourth quarter. CKW Financial Group now owns 955 shares of the medical equipment provider’s stock valued at $101,000 after buying an additional 100 shares in the last quarter. KBC Group NV grew its position in Zimmer Biomet by 15.7% during the fourth quarter. KBC Group NV now owns 29,264 shares of the medical equipment provider’s stock worth $3,092,000 after buying an additional 3,977 shares in the last quarter. Finally, Blue Trust Inc. increased its stake in Zimmer Biomet by 18.3% during the 4th quarter. Blue Trust Inc. now owns 2,033 shares of the medical equipment provider’s stock worth $219,000 after acquiring an additional 314 shares during the period. 88.89% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

ZBH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upgraded Zimmer Biomet from a “neutral” rating to an “overweight” rating and upped their target price for the company from $125.00 to $128.00 in a research report on Tuesday, December 17th. Oppenheimer reduced their price target on shares of Zimmer Biomet from $145.00 to $135.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 15th. Wells Fargo & Company boosted their price objective on shares of Zimmer Biomet from $110.00 to $117.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. Royal Bank of Canada raised their target price on Zimmer Biomet from $120.00 to $125.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Finally, Stifel Nicolaus boosted their price target on Zimmer Biomet from $130.00 to $138.00 and gave the stock a “buy” rating in a report on Thursday, January 23rd. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $124.11.

Zimmer Biomet Stock Performance

Shares of ZBH stock opened at $111.93 on Thursday. The stock has a market capitalization of $22.28 billion, a PE ratio of 21.15, a PEG ratio of 1.88 and a beta of 1.02. The business’s 50 day simple moving average is $107.87 and its 200 day simple moving average is $108.20. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.36 and a quick ratio of 0.70. Zimmer Biomet Holdings, Inc. has a one year low of $100.67 and a one year high of $133.90.

Zimmer Biomet (NYSE:ZBH) last announced its earnings results on Wednesday, October 30th. The medical equipment provider reported $1.74 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.74. The business had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.80 billion. Zimmer Biomet had a net margin of 14.27% and a return on equity of 12.95%. Zimmer Biomet’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.65 earnings per share. As a group, research analysts forecast that Zimmer Biomet Holdings, Inc. will post 7.99 earnings per share for the current year.

Zimmer Biomet Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Monday, December 30th will be given a dividend of $0.24 per share. The ex-dividend date is Monday, December 30th. This represents a $0.96 annualized dividend and a dividend yield of 0.86%. Zimmer Biomet’s payout ratio is 18.25%.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.